[{"id":"855dd99b-0486-413b-8745-83182704b7d8","acronym":"","url":"https://clinicaltrials.gov/study/NCT02582359","created_at":"2021-01-18T12:31:30.489Z","updated_at":"2025-02-25T14:57:23.823Z","phase":"Phase 1","brief_title":"MLN 9708 in Induction and Consolidation for Adults With AML \u003e= 60 Years of Age","source_id_and_acronym":"NCT02582359","lead_sponsor":"Massachusetts General Hospital","biomarkers":" CD74","pipe":" | ","alterations":" CD74 expression","tags":["CD74"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD74 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cytarabine • Ninlaro (ixazomib) • daunorubicin"],"overall_status":"Completed","enrollment":" Enrollment 39","initiation":"Initiation: 01/01/2016","start_date":" 01/01/2016","primary_txt":" Primary completion: 04/01/2022","primary_completion_date":" 04/01/2022","study_txt":" Completion: 04/01/2022","study_completion_date":" 04/01/2022","last_update_posted":"2022-08-24"},{"id":"ac25ec3e-fc3f-4378-9027-ddc11a11d079","acronym":"","url":"https://clinicaltrials.gov/study/NCT02761863","created_at":"2021-01-18T13:32:39.989Z","updated_at":"2024-07-02T16:37:13.706Z","phase":"","brief_title":"Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma","source_id_and_acronym":"NCT02761863","lead_sponsor":"Ain Shams University","biomarkers":" CD74","pipe":" | ","alterations":" CD74 expression","tags":["CD74"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD74 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e pemetrexed"],"overall_status":"Unknown status","enrollment":" Enrollment 100","initiation":"Initiation: 07/30/2019","start_date":" 07/30/2019","primary_txt":" Primary completion: 01/30/2020","primary_completion_date":" 01/30/2020","study_txt":" Completion: 07/30/2021","study_completion_date":" 07/30/2021","last_update_posted":"2018-02-23"}]